Late Stage Investors & VC Firms in North America

1701 firms in this list, with a median first check of $1M. 371 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
10 10 Point Capital DWMGSPTW5 people	88🔒	Atlanta	US	Growth–Late Stage	—	+ Add to CRM
BE Bendigo Partners DHJLMDPD5 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
CO Columbia Partners Private Capital CDMKTBJC5 people	88🔒	Bethesda	US	Growth–Late Stage	—	+ Add to CRM
SP Springboard Growth Capital KKLWAWJD5 people	88🔒	New York	US	Growth–Late Stage	—	+ Add to CRM
FU FundThrough SU1 person	88🔒	Toronto	CA	Seed–Late Stage	$1M	+ Add to CRM
LE Level Eight Ventures SHDKRPSJ4 people	88🔒	Ann Arbor	US	Seed–Late Stage	—	+ Add to CRM
BL Blazar Ventures, LLC JGMFRP3 people · Leads rounds	88🔒	Alexandria	US	Seed–Late Stage	—	+ Add to CRM
BL Blue Heron Capital ATTBKMMA6 people	88🔒	Richmond	US	Seed–Late Stage	—	+ Add to CRM
AI AInBC RGABBTDB11 people	88🔒	Vancouver	CA	Pre-Seed–Late Stage	—	+ Add to CRM
CL Clarus Ventures DHKCNGNJ8 people	88🔒	Menlo Park	US	Pre-Seed–Late Stage	—	+ Add to CRM
GR Green Acre Capital MSSDTSWB5 people	88🔒	Toronto	CA	Growth–Late Stage	—	+ Add to CRM
JU Jumpstart Health Investors KCMWVGJG5 people	88🔒	Nashville	US	Pre-Seed–Late Stage	—	+ Add to CRM
PA Palla Capital SPCCSKWA5 people	88🔒	Darien	US	Seed–Late Stage	—	+ Add to CRM
FI FinSight Ventures AGPG2 people	88🔒	Palo Alto	US	Seed–Late Stage	—	+ Add to CRM
GR Greenspring Associates BPJA2 people	88🔒	Portland	US	Series A–Late Stage	—	+ Add to CRM
MA Madison Bay Capital Partners ESSR2 people	88🔒	New York	US	Growth–Late Stage	$5M – $25M	+ Add to CRM
HE HealthCare Ventures, LLC AL1 person	88🔒	Cambridge	US	Series A–Late Stage	$1M – $20M	+ Add to CRM
AL Aldrich MBRZRZ3 people	88🔒	McLean	US	Seed–Late Stage	—	+ Add to CRM
EX Exit 156 Capital BKJRMN3 people · Follows rounds	88🔒	Collegeville	US	Growth–Late Stage	—	+ Add to CRM
SI Silverleaf Venture Partners, LLC DJAMCC3 people	88🔒	Fort Myers	US	Series A–Late Stage	—	+ Add to CRM
VE venn growth partners	88🔒	Toronto	CA	Series C–Late Stage	$10M – $50M	+ Add to CRM
FS FS Investments DAAWHFBM4 people	88🔒	Philadelphia	US	Growth–Late Stage	—	+ Add to CRM
PS PSP Investments private equity ODCLSBCP4 people · Leads rounds	88🔒	Montréal	CA	Growth–Late Stage	$1.5B	+ Add to CRM
HE Heron Capital GMKLSR3 people · Leads rounds	88🔒	Indianapolis	US	Series A–Late Stage	$10M	+ Add to CRM

10 Point Capital

AtlantaGrowth–Late Stage

DWMGSPTW5 people

Bendigo Partners

New YorkSeed–Late Stage

DHJLMDPD5 people

Columbia Partners Private Capital

BethesdaGrowth–Late Stage

CDMKTBJC5 people

Springboard Growth Capital

New YorkGrowth–Late Stage

KKLWAWJD5 people

FundThrough

TorontoSeed–Late Stage$1M

SU1 person

Level Eight Ventures

Ann ArborSeed–Late Stage

SHDKRPSJ4 people

Blazar Ventures, LLC

AlexandriaSeed–Late Stage

JGMFRP3 people

Blue Heron Capital

RichmondSeed–Late Stage

ATTBKMMA6 people

AInBC

VancouverPre-Seed–Late Stage

RGABBTDB11 people

Clarus Ventures

Menlo ParkPre-Seed–Late Stage

DHKCNGNJ8 people

Green Acre Capital

TorontoGrowth–Late Stage

MSSDTSWB5 people

Jumpstart Health Investors

NashvillePre-Seed–Late Stage

KCMWVGJG5 people

Palla Capital

DarienSeed–Late Stage

SPCCSKWA5 people

FinSight Ventures

Palo AltoSeed–Late Stage

AGPG2 people

Greenspring Associates

PortlandSeries A–Late Stage

BPJA2 people

Madison Bay Capital Partners

New YorkGrowth–Late Stage$5M – $25M

ESSR2 people

HealthCare Ventures, LLC

CambridgeSeries A–Late Stage$1M – $20M

AL1 person

Aldrich

McLeanSeed–Late Stage

MBRZRZ3 people

Exit 156 Capital

CollegevilleGrowth–Late Stage

BKJRMN3 people

Silverleaf Venture Partners, LLC

Fort MyersSeries A–Late Stage

DJAMCC3 people

venn growth partners

TorontoSeries C–Late Stage$10M – $50M

FS Investments

PhiladelphiaGrowth–Late Stage

DAAWHFBM4 people

PSP Investments private equity

MontréalGrowth–Late Stage$1.5B

ODCLSBCP4 people

Heron Capital

IndianapolisSeries A–Late Stage$10M

GMKLSR3 people

Data sourced from public filings and firms' own websites — see our methodology.